Open Access Green as soon as Postprint is submitted to ZB.
Small molecule screening at Helmholtz Zentrum München - from biology to molecules.
Comb. Chem. High Throughput Screen. 7, 266-271 (2014)
Within the last few years the Helmholtz Zentrum München has established several initiatives enabling the translation of basic research results into discovery of novel small molecules that affect pathomechanisms of chronic and complex diseases. Here, one of the main operations is the Assay Development and Screening Platform (ADSP) that has state-of-the-art equipment for compound screening and provides knowledge in a variety of biochemical or cell-based phenotypic assays. In particular, ADSP has a strong focus on complex assays such as high-content screening in stem cells that are likely to provide an innovative approach complementary to biochemical assays for the discovery of novel small molecules modulating key biological processes.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
1.925
0.618
3
3
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
Academic Screening ; Assay Development ; Drug Discovery ; High Content Screening ; Hts ; Liquid Handling ; Phenotypic Screening
Language
english
Publication Year
2014
HGF-reported in Year
2014
ISSN (print) / ISBN
1386-2073
e-ISSN
1875-5402
Quellenangaben
Volume: 7,
Issue: 3,
Pages: 266-271
Publisher
Bentham Science Publishers
Publishing Place
Sharjah
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Enabling and Novel Technologies
PSP Element(s)
G-505293-001
PubMed ID
24409952
WOS ID
WOS:000333188300009
Scopus ID
84897980481
Erfassungsdatum
2014-02-04